MDNA Life Sciences Inc. (MDLS)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	51.95M
Revenue (ttm)	3.60M
Net Income (ttm)	-3.79M
Shares Out	9.45M
EPS (ttm)	-0.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MDLS

MDNA Life Sciences is a life sciences company focused on the development of liquid biopsy tests based on the mitochondrial genome. We have discovered novel biomarkers and designed laboratory assays, which we refer to as our Mitomic Technology, that are intended to use mitochondrial DNA to detect cancer earlier, more accurately, and less invasively than traditional methods. Though we have no commercially available FDA or foreign regulator approved products, we have licensed our intellectual property related to the Mitomic prostate cancer biomark...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2002
• Employees: 12
• Stock Exchange: NASDAQ
• Ticker Symbol: MDLS